MOG and optic neuritis: The prompt administration of intravenous methylprednisolone (IVMP) has been found to improve the chances of favorable visual acuity in both NMOSD- and MOG-related optic neuritis patients [5,7,8], and baseline visual status has been identified as a factor that can affect visual outcomes after treatment [9,10,11].